
### [MONDO:0019410](http://purl.obolibrary.org/obo/MONDO_0019410)
**Label:** Nodulosis-arthropathy-osteolysis syndrome

**Subclasses:** [MONDO:0009809](http://purl.obolibrary.org/obo/MONDO_0009809) (multicentric osteolysis, Nodulosis, and arthropathy), [MONDO:0010201](http://purl.obolibrary.org/obo/MONDO_0010201) (Winchester syndrome), 

**Mapped go classes:** [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0003407](http://purl.obolibrary.org/obo/GO_0003407) (neural retina development), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042074](http://purl.obolibrary.org/obo/GO_0042074) (cell migration involved in gastrulation), [GO:0001955](http://purl.obolibrary.org/obo/GO_0001955) (blood vessel maturation), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity), [GO:0030574](http://purl.obolibrary.org/obo/GO_0030574) (collagen catabolic process), [GO:0030017](http://purl.obolibrary.org/obo/GO_0030017) (sarcomere), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0045906](http://purl.obolibrary.org/obo/GO_0045906) (negative regulation of vasoconstriction), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:0060346](http://purl.obolibrary.org/obo/GO_0060346) (bone trabecula formation), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0071392](http://purl.obolibrary.org/obo/GO_0071392) (cellular response to estradiol stimulus), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001968](http://purl.obolibrary.org/obo/GO_0001968) (fibronectin binding), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0014012](http://purl.obolibrary.org/obo/GO_0014012) (peripheral nervous system axon regeneration), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0007566](http://purl.obolibrary.org/obo/GO_0007566) (embryo implantation), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0045089](http://purl.obolibrary.org/obo/GO_0045089) (positive regulation of innate immune response), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 52.79%
- [GO:0060346](http://purl.obolibrary.org/obo/GO_0060346) (bone trabecula formation) 52.63%
- [GO:0014012](http://purl.obolibrary.org/obo/GO_0014012) (peripheral nervous system axon regeneration) 52.63%
- [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation) 52.63%
- [GO:0007566](http://purl.obolibrary.org/obo/GO_0007566) (embryo implantation) 52.63%
- [GO:0003407](http://purl.obolibrary.org/obo/GO_0003407) (neural retina development) 52.63%
- [GO:0001955](http://purl.obolibrary.org/obo/GO_0001955) (blood vessel maturation) 52.63%
- [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development) 52.63%
- [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development) 52.63%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 39.89%
- [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration) 37.99%
- [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration) and [GO:0061564](http://purl.obolibrary.org/obo/GO_0061564) (axon development) 37.99%
- [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration) and [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury) 37.99%
- [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding) and [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration) 37.99%
- [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration) and ([GO:0005805](http://purl.obolibrary.org/obo/GO_0005805) (obsolete ER-Golgi transport vesicle) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 37.99%


